Marijuana Stocks: Tuesday News Recap

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a US public biotechnology company dedicated to the development of personalized anti-cancer diagnostics and palliative treatments based on the therapeutic properties of cannabis, announced the appointment of Yasha Borstein as the company’s Chief Data Officer.

With extensive experience spanning big data analytics, machine learning, AI and software development alongside an extended track record in enterprise risk management, Yasha Borstein will oversee the design and implementation of a data governance policy for the company.

At the company’s R&D base in Israel, Cannabics is conducting scientific research on cannabinoid formulations to deliver innovative diagnostic procedures for screening cancer. Utilizing advanced detection systems and personalized bioinformatics tools, the biotech company is engaged in delivering supportive data upon which cancer patients and doctors can make informed choices about treatments and possible side effects.

Shares of CNBX traded down 0.8% closing trading today at $1.29 per share with 155k shares changing hands. After a major run to start 2018 the stock has pulled back and is consolidating in the $1.20 – $.130 range.

CR Brands – a division of CannaRoyalty Corp. (CSE: CRZ) (OTCQX: CNNRF), an operator in the legal cannabis industry – announced today that it has won a total of six 2017 Hempcon Cup Awards notably including Best Candy, Best Edible, and the Best Connoisseur Edible for its work with Soul Sugar Kitchen brand. Based in California, Soul Sugar Kitchen has created a line of multiple award-winning gourmet cannabis edibles which includes peanut butter cups, savory mixes and jellies, all of which are available for purchase in California through the distribution network of River Collective, another CannaRoyalty investee.

CRZ saw its shares drop 4.3% today closing the day at $4.28 on volume of 241k. After pulling back to start the month CRZ has bounced off the $3.50 mark gaining nearly $1 per share in the last 2 weeks.

Canopy Growth Corporation (TSX: WEED) (OTCPK: TWMJF)  is pleased to announce that it has received a cultivation licence for the first of its two sites operating under the BC Tweed Joint Venture Inc. (“BC Tweed”) banner.

The rapid licensing of the Aldergrove site, the largest federally licensed cannabis site anywhere in the world, continues a pattern of professional execution for the Company as it prepares to meet an unprecedented increase in demand in a few short months once legal adult-use markets commence. The initial licensing covers over 400,000 sq. ft. of growing space, allowing vegetative growth so that the mature plants can be spread into the full 1.3 million sq. ft. in the coming months for flowering and ultimate harvest.

Shares of WEED had a very strong day closing up 11.7% at $29.60 with solid volume of 11m. The stock seems to have broken out of its consolidation range. WEED closed today just off the HOD indicating the stock could push higher again tomorrow.

Aphria Inc. (TSX: APH) (OTCQB: APHQF) announces today that it has entered into an amending agreement to the previously announced arrangement agreement dated January 28, 2018 between Aphria and Nuuvera Inc. whereby the Company and Nuuvera have agreed to amend the Arrangement Agreement to reduce both the required level of unrestricted cash and the consideration payable to holders of Nuuvera’s common shares (each a “Nuuvera Share“). The consideration under the Amendment has been reduced from $1.00 in cash plus 0.3546 of an Aphria common share (each an “Aphria Share“) for each Nuuvera Share to $0.60 in cash plus 0.3546 of an Aphria Share for each Nuuvera Share.

APH saw its stock bounce sharply today closing the trading session up 6.2% at $14.93 per share with 6.6m shares changing hands. After starting 2018 on a tear APH has given back some of those gains and its currently forming a base between $13 and $16 per share.

Marapharm Ventures Inc. (CSE: MDM) (OTXQX: MRPHF), is pleased to announce its inclusion in the newly created Horizons Emerging Marijuana Growers Index ETF (AQN:HMJR) (“HMJR ETF” or the “Index”) which began trading on February 14, 2018.

HMJR is designed to provide exposure to the performance of a basket of primarily North American publicly-listed small capitalization companies involved in the cultivation, production and/or distribution of marijuana. Stocks held within the Index will generally have an initial market capitalization of at least $50 million and less than $500 million. It is expected that no issuer will represent more than 8% of the Index on each rebalance.

“We are very pleased to be included in this new ETF and have expectations that the share price and liquidity of companies like ours will be enhanced proportionately by the buying power of an ETF. This ETF was specifically constructed to incorporate companies with operations in certain U.S. states, where cannabis use has been legalized under state law. These were largely overlooked by most prior ETF offerings,” said Linda Sampson, CEO of Marapharm.

Shares of MDM closed trading today down 1.3% at $0.76 per share on volume of 226k. It will be interesting to see how MDM‘s inclusion in the new ETF effects the share price.

Newstrike Resources Ltd. (TSXV: HIP) is pleased to announce that in connection with its previously announced short form prospectus offering of 60,610,000 units of the Company at $1.32 per Unit which closed on February 16, 2018, the underwriters have determined to fully exercise their over-allotment option to acquire an additional 9,091,500 Units at $1.32 per Unit to raise additional gross proceeds of $12,000,780, for aggregate gross proceeds under the Offering of $92,005,980.  Closing of the over-allotment option is expected to occur on February 22, 2018.  The Offering is being completed pursuant to an underwriting agreement with a syndicate of underwriters co-led by INFOR Financial Inc. and Cormark Securities Inc. and including Eight Capital and Haywood Securities Inc.

Each Unit is comprised of one common share of the Company and one common share purchase warrant. Each Warrant shall entitle the holder thereof to purchase one additional Common Share at an exercise price of $1.75, for a period of 24 months following closing. In the event that the volume weighted average trading price of the Common Shares for ten (10) consecutive trading days exceeds $2.60, the Company shall have the right, subject to the approval of the TSX Venture Exchange, to accelerate the expiry date of the Warrants upon not less than fifteen (15) trading days’ notice. The Company has applied to list the Warrants for trading on the TSXV.

HIP saw its stock drop 1% today closing the trading day at $1.03 per share with over 8.8m shares traded. After running to over $3 to start 2018 the stock has declined sharply and seems to be finding support in the $1 range.

The Cannabis Investor is always researching new trade ideas which have the makings for large market moves. Traders are urged to follow our parent outlet, The Wealthy Venture Capitalist & The Cannabis Investor, on social media (see below) to stay apprised. We are an anti-email media outlet, and as such will only be releasing our reports/ updates/ news through Twitter and Facebook, as well as newswire.


Join the largest Cannabis Investing page on Facebook:

To receive text Message alerts when new articles are released click here:

Join our Email list:

Follow us on Instagram:

Follow us on Twitter: @CannaInvestor
Like us on


Leave a Reply

Your email address will not be published. Required fields are marked *

pour la musculation tamoxifen buylivraison anonyme, prix favorable As a rule, the infection occurs during penetrative sexual intercourse buy metronidazole no prescription moist environment and can remain viable. cialis 20mg rezeptfreider Wirkstoff des Arzneimittels wird nicht verlassen, Zweifel an der Wirksamkeit der Pillen ein bewährtes Medikament zur Behandlung von BPH in einer Dosierung von 10 mg, die Möglichkeit gibt, ein neues Potential des Penis, um zu versuchen buy Retin AThis drug will no doubt help to solve the problem with acne in young people from 16 years, thanks to the active ingredient of this cream you will experience relief, people will stop laughing at you Diagnosticare la causa della disfunzione erettilecomprar cilaiscosì spesso il trattamento può comportare molteplici tecniche. Comprar cialis en línea

Wealthy Venture Capitalist